SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:oru-84937"
 

Sökning: id:"swepub:oai:DiVA.org:oru-84937" > Anti-HCV prevalence...

Anti-HCV prevalence and risk factor-based screening for hepatitis C in pregnant women and their partners in Sweden

Millbourn, Charlotta (författare)
Karolinska Institutet
Lybeck, Charlotte, 1979- (författare)
Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases
Einberg, Afrodite Psaros (författare)
Karolinska Institutet
visa fler...
Nordin, Margareta (författare)
Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
Lindh, Gudrun (författare)
Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
Hökeberg, Ingegerd (författare)
Department of Communicable Disease Prevention and Control, Stockholm County Council, Stockholm, Sweden
Fredlund, Hans (författare)
Department of Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
Fischler, Björn (författare)
Karolinska Institutet
Fadl, Helena, 1965- (författare)
Örebro universitet,Institutionen för medicinska vetenskaper,Department of Obstetrics and Gynecology
Duberg, Ann-Sofi, Docent, 1957- (författare)
Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases
Lindahl, Karin (författare)
Karolinska Institutet
visa färre...
 (creator_code:org_t)
2020-07-11
2020
Engelska.
Ingår i: Infectious Diseases. - : Taylor & Francis. - 2374-4235 .- 2374-4243. ; 52:11, s. 776-785
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: The hepatitis C virus (HCV) prevalence in Sweden is estimated to be <0.5%, but unclear in pregnant women. The dominating route of transmission is drug use (DU), blood transfusions constituted a risk before 1992. The aim was to examine the anti-HCV prevalence and risk factors for HCV among pregnant women and their partners to evaluate screening strategies.Methods: Pregnant women and partners in Örebro County and in southern Stockholm were offered HCV-screening when visiting an antenatal clinic in 2013-2016, and completed a questionnaire concerning the country of birth, knowledge of HCV-status and HCV risk factors.Results: In Örebro 2,827 pregnant women and 707 partners, and in Stockholm 1,281 pregnant women and 320 partners participated. Anti-HCV was positive in 34 (0.7%) (25 pregnant women) and the associated risk factors were DU (n = 27), partner with HCV (n = 24) and not born in Sweden (n = 8). HCV RNA was positive in 23 (0.4%), 4 previously unknown and 10 who had been lost to follow-up. The most effective risk factor-based screening model for pregnant women included DU, blood transfusions, born in high prevalence country, partner with HCV, resulting in 538 (13%) pregnant women tested with 96% sensitivity, 87% specificity.Conclusions: In this study of expecting parents in two Swedish regions, the anti-HCV prevalence was 0.7% and 0.4% were viraemic, of which about 60% were previously unknown or lost to follow-up. Awaiting more studies, including cost-benefit analysis evaluating universal screening, we recommend this improved risk factor-based screening model to identify HCV-infected individuals who need follow-up and therapy.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Nyckelord

HCV
HCV RNA
pregnancy
MTCT
IDU
risk factor-based

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy